載入...
A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma
Lenalidomide (also known as Revlimid(®), CC-5013) is an immunomodulatory derivative of thalidomide and has more potent anti-tumor and anti-inflammatory effects than thalidomide. The molecular mechanisms of anti-tumor activity of lenalidomide have been extensively studied in multiple myeloma (MM) bot...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2503648/ https://ncbi.nlm.nih.gov/pubmed/18728702 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|